| |
| |
|
| Insider
Information: |
Truex Paul F |
| Relationship: |
Director |
| City: |
Hayward |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
95,050 |
|
|
Indirect Shares
|
16,793 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
111,843 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anthera Pharmaceuticals Inc |
ANTH |
|
2016-09-20 |
0 |
2017-09-07 |
16,793 |
Premium* |
|
|
Trius Therapeutics Inc |
TSRX |
Director |
2011-08-29 |
13,270 |
2013-09-11 |
0 |
Premium* |
|
|
Milestone Pharmaceuticals Inc. |
MIST |
Director |
2022-05-31 |
81,780 |
2022-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MIST |
Milestone Pharmaceuticals... |
Director |
– • – |
2022-05-31 |
4 |
OE |
$1.12 |
$115,795 |
D/D |
76,780 |
76,780 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and Chief Executive |
• • – |
2012-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
37,984 |
79,755 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• – – |
2013-06-30 |
4/A |
A |
$3.30 |
$20,625 |
I/I |
6,250 |
80,190 |
0 |
- |
|
| MIST |
Milestone Pharmaceuticals... |
Director |
– • – |
2022-05-31 |
4 |
B |
$5.60 |
$28,000 |
D/D |
5,000 |
81,780 |
2.39 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2011-05-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,122 |
86,000 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• – – |
2014-12-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,500 |
89,337 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Executive Officer |
• – – |
2015-06-30 |
5 |
GD |
$0.00 |
$0 |
I/I |
12,500 |
89,337 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2011-08-08 |
4 |
OE |
$0.26 |
$13,000 |
D/D |
50,000 |
90,512 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2011-03-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
693,253 |
91,122 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2011-05-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
91,122 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Executive Officer |
• – – |
2016-09-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
5,008 |
94,345 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Executive Officer |
• – – |
2015-06-30 |
5 |
A |
$0.00 |
$0 |
I/I |
12,500 |
101,837 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2011-04-13 |
4 |
OE |
$0.26 |
$7,800 |
D/D |
30,000 |
121,122 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• – – |
2013-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
135,644 |
135,644 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• – – |
2013-05-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
100,000 |
591,537 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• – – |
2014-03-25 |
4 |
A |
$3.30 |
$20,625 |
I/I |
6,250 |
597,787 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• – – |
2014-03-25 |
4 |
A |
$3.30 |
$20,625 |
I/I |
6,250 |
597,787 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and Chief Executive |
• • – |
2012-01-17 |
4 |
AS |
$6.75 |
$101,250 |
I/I |
(15,000) |
627,125 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2011-10-21 |
4 |
AS |
$6.25 |
$145,219 |
I/I |
(23,235) |
637,125 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2011-12-15 |
4 |
AS |
$6.34 |
$95,066 |
I/I |
(15,000) |
642,125 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2012-06-29 |
4 |
B |
$0.76 |
$15,200 |
I/I |
20,000 |
645,125 |
2.58 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2011-11-15 |
4 |
AS |
$6.96 |
$208,704 |
I/I |
(30,000) |
657,125 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2011-10-18 |
4 |
AS |
$6.25 |
$42,156 |
I/I |
(6,745) |
660,360 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEOOfficer |
• • – |
2010-02-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
662,967 |
|
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
President and CEO |
• • – |
2010-03-01 |
4 |
B |
$7.05 |
$7,117 |
D/D |
1,000 |
663,967 |
2.81 |
- |
|
64 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
